259 related articles for article (PubMed ID: 3143763)
1. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
Rubinstein LJ; Stein KE
J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
[TBL] [Abstract][Full Text] [Related]
2. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. I. Ontogeny.
Rubinstein LJ; Stein KE
J Immunol; 1988 Dec; 141(12):4352-6. PubMed ID: 3143762
[TBL] [Abstract][Full Text] [Related]
3. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR
Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277
[TBL] [Abstract][Full Text] [Related]
4. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
5. Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.
Lifely MR; Esdaile J
Immunology; 1991 Nov; 74(3):490-6. PubMed ID: 1722773
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
7. Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.
García-Ojeda PA; Monser ME; Rubinstein LJ; Jennings HJ; Stein KE
Infect Immun; 2000 Jan; 68(1):239-46. PubMed ID: 10603394
[TBL] [Abstract][Full Text] [Related]
8. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
Jennings HJ; Gamian A; Michon F; Ashton FE
J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
[TBL] [Abstract][Full Text] [Related]
9. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
11. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE
Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556
[TBL] [Abstract][Full Text] [Related]
12. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
13. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
[TBL] [Abstract][Full Text] [Related]
14. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.
Jennings HJ; Roy R; Michon F
J Immunol; 1985 Apr; 134(4):2651-7. PubMed ID: 2579148
[TBL] [Abstract][Full Text] [Related]
15. Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide.
Hutchins WA; Carlone GM; Westerink MA
J Infect Dis; 1999 Jun; 179(6):1433-40. PubMed ID: 10228065
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
Menéndez T; Santiago-Vispo NF; Cruz-Leal Y; Coizeau E; Garay H; Reyes O; Batista Y; Cobas K; Carmenate T; Chinea G; Guillén G
Int J Med Microbiol; 2011 Jan; 301(1):16-25. PubMed ID: 20708963
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
Colino J; Outschoorn I
J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
[TBL] [Abstract][Full Text] [Related]
19. Avidity maturation, repertoire shift, and strain differences in antibodies to bacterial levan, a type 2 thymus-independent polysaccharide antigen.
Boswell CM; Stein KE
J Immunol; 1996 Sep; 157(5):1996-2005. PubMed ID: 8757320
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.
Westerink MA; Campagnari AA; Wirth MA; Apicella MA
Infect Immun; 1988 May; 56(5):1120-7. PubMed ID: 3128477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
